Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

711
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
711
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

17.7K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.7K
Inflammation01:38

Inflammation

63.3K
Overview
63.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

668
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
668
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

524
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
524

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing incidence and serotype trends in ANCA-associated vasculitis: a 30-year population-based study in Norfolk, UK.

Rheumatology (Oxford, England)·2026
Same author

Cutaneous Manifestations of Vasculitis: A Cross-Sectional Analysis From an International Cohort.

International journal of dermatology·2026
Same author

Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis.

RMD open·2025
Same author

Idiopathic polyarteritis nodosa - does it still exist? Viewpoint 1: as our knowledge makes progress, idiopathic polyarteritis nodosa is fading away.

Rheumatology (Oxford, England)·2025
Same author

Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study.

Journal of neurology·2024
Same author

Classification and epidemiology of vasculitis: Emerging concepts.

Best practice & research. Clinical rheumatology·2023
Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026
Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026
Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026
Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026
Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
See all related articles

Related Experiment Video

Updated: Mar 10, 2026

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.6K

Vasculitis and inflammatory arthritis.

Richard A Watts1, David G I Scott2

  • 1Norwich Medical School, University of East Anglia, Norwich, UK; Ipswich Hospital NHS Trust, Ipswich, UK.

Best Practice & Research. Clinical Rheumatology
|December 15, 2016
PubMed
Summary
This summary is machine-generated.

Rheumatoid vasculitis, once common in inflammatory arthritis, is now rare due to early methotrexate use. Despite treatment advances like rituximab, mortality remains high, and other inflammatory arthritis vasculitis treatments are empirical.

Keywords:
Ankylosing spondylitisPsoriatic arthritisRheumatoid arthritisVasculitis

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.7K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 10, 2026

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

10.6K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.7K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.3K

Area of Science:

  • Rheumatology
  • Immunology
  • Systemic autoimmune diseases

Background:

  • Vasculitis frequently occurs in inflammatory arthritis, with rheumatoid vasculitis being the most recognized type.
  • Systemic rheumatoid vasculitis incidence has significantly decreased since the widespread adoption of methotrexate in the 1990s, making it a rare condition.
  • Current treatment for rheumatoid vasculitis typically involves glucocorticoids and cyclophosphamide, with rituximab gaining importance.

Purpose of the Study:

  • To review the current understanding of vasculitis in inflammatory arthritis.
  • To highlight the changing incidence and treatment of rheumatoid vasculitis.
  • To discuss the challenges in managing vasculitis in other inflammatory arthropathies.

Main Methods:

  • Literature review of vasculitis in inflammatory arthritis.
  • Analysis of treatment strategies and outcomes for rheumatoid vasculitis.
  • Comparison of vasculitis management across different inflammatory arthritis types.

Main Results:

  • Systemic rheumatoid vasculitis is now rare due to early methotrexate intervention.
  • Mortality rates for rheumatoid vasculitis remain high despite treatment advancements.
  • Treatment for vasculitis in other inflammatory arthritis types is largely empirical and less well-documented.

Conclusions:

  • Rheumatoid vasculitis, while less common, still carries a high mortality risk.
  • Rituximab shows promise in treating rheumatoid vasculitis, aligning with its use in other vasculitides.
  • Further research is needed to establish effective, evidence-based treatments for vasculitis in less common inflammatory arthritis conditions.